Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04081636 · ClinicalTrials.gov registry record · NA
Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications
A NA study, sponsored by Albany Medical College.
- Completed
- Registry status
- NA
- Development phase
- 840
- Enrollment target
NCT04081636 is a NA study that has completed, run by Albany Medical College. The registered enrollment target is 840 participants.
The verdict
NCT04081636, a NA study, has completed, sponsored by Albany Medical College.
- COMPLETED
- Registry status
- NA
- Development phase
- 840 participants
- Enrollment target
Study Summary
This study evaluates the difference between 2 prostate biopsy methods, transrectal (through the rectal wall) and transperineal (through the skin) needle biopsy. Men who are in need of prostate biopsy due to clinical suspicions of prostate cancer will be randomly assigned (1:1) to either transrectal or transperineal approach. This research study will scientifically determine if one biopsy method is better than the other in reducing complications and improving cancer detection.
Interventions
- PROCEDURE Systematic Transrectal biopsy (TR-Bx)
- PROCEDURE Targeted Transrectal biopsy (TR-Bx)
- PROCEDURE Systematic Transperineal biopsy (TP-Bx)
- PROCEDURE Targeted Transperineal biopsy (TP-Bx)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 840 participants |
| Start Date | 2019-09-02 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04081636
The ClinicalTrials.gov registry entry for NCT04081636 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 840 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albany Medical College, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Systematic Transrectal biopsy (TR-Bx) is the first listed.
NCT04081636 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04081636 about?
NCT04081636 is a clinical study titled "Prostate Biopsy, Transrectal vs. Transperineal: Efficacy and Complications". This study evaluates the difference between 2 prostate biopsy methods, transrectal (through the rectal wall) and transperineal (through the skin) needle biopsy. Men who are in need of prostate biopsy due to clinical suspicions of prostate cancer will be randomly assigned (1:1) to either transrectal...
What is the current status of trial NCT04081636?
This trial is currently completed. It is a NA study. The enrollment target is 840 participants. The study started on 2019-09-02. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT04081636?
The interventions under investigation include: Systematic Transrectal biopsy (TR-Bx) (PROCEDURE), Targeted Transrectal biopsy (TR-Bx) (PROCEDURE), Systematic Transperineal biopsy (TP-Bx) (PROCEDURE), Targeted Transperineal biopsy (TP-Bx) (PROCEDURE).
Who is sponsoring clinical trial NCT04081636?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.